Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

What a year! What do you think was the most important news in the United States in 2024? This list probably doesn’t reflect that. Rather, it shows what you, the readers, were looking at on ...

HFpEF refers to when the heart is unable to pump enough blood to meet the body’s needs. Eli Lilly said the condition is linked to a “high burden” of symptoms and physical limitations that affect a ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

Elon Musk took to X on Wednesday to revel in the Christmas spirit. He also reportedly credited Mounjaro for his weight loss.